Baby formula crisis: Abbott enriched shareholders as factory needed repairs, records show
U.S. · BUSINESS · HEALTH
May 20, 20225 min read942 words
Published: May 20, 2022  |  5 min read942 words
This article is more than 3 months oldThis article is more than 3 months oldEconomists condemn ‘rot’ in system after manufacturer issued billions in stock buybacks despite problems at Michigan factorySupported byFirst published on Fri 20 May 2022 06.15 EDTA deadly bacteria outbre...
Baby formula crisis: Abbott enriched shareholders as factory needed repairs, records show Read more

No article scores yet.

There are no critic or public scores for this article yet.
Investigative1
critic reviews: 0
public reviews: 1
No reviews
img-trusted
79%
critic score
29 reviews
img-trusted
66%
public score
115 reviews
img-contested
N/A
critic score
0 reviews
img-contested
N/A
public score
1 reviews

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

Investigative
May 24
A very good, honest investigative look into the baby formula shortage and limited cases of bacteria entering the supply. The article mostly covers the way share buybacks are used to benefit investors rather than invest in repairs and R&D that many companies actually need, but neglect in exchange for investor returns. It also asks the question of whether or not share buybacks should be legal, as they could be considered a form of manipulation and were illegal until just 1982.
May 24
Is this helpful?